Manufacturer record

Deep Pharma: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

14 batches manufactured by Deep Pharma (Gujarat) were declared Not of Standard Quality between April 2020 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

14 records linked to Deep Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
14Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Apr 2020 to May 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

14
NSQ batches since 2020
9
Products affected
Description
Most common failure
May 2026
Latest alert

Flagged batches per year

2020 · 12021 · 62022 · 12023 · 32025 · 22026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Levocetirizine Dihydrochloride Syrup 1C0149Mfg 2026-03 · Exp 2028-02 The sample does not conform to Manufacturers specification with respect to the test of Microbial contamination (Total aerobic viable count).Microbial limits CDTL, MumbaiCDSCO lab May 2026
Dextromethorphan Hydrobromide Syrup IP. 1B0453Mfg 2026-07 · Exp 2027-06 The sample received does not conform to I.P. 2022 with respect to the test for Microbial limit testMicrobial limits CDTL, MumbaiCDSCO lab Nov 2025
Calcium Carbonate Tablets IP 3B1181Mfg 2025-06 · Exp 2027-05 Dissolution (Calcium)Dissolution Food & Drugs Laboratory, VadodaraState lab Nov 2025
Metformin Hydrochloride Tablets IP GT0712Mfg 2023-08 · Exp 2025-07 DescriptionDescription CDTL MumbaiCDSCO lab Dec 2023
Iron and Folic Acid (IFA) Tablets I.P. (Small)(Pink) 401Mfg 2023-01 · Exp 2024-12 Description & Uniformity of ContentDescription CDL KolkataCDSCO lab Sep 2023
Neomycin Sulphate Ointment USP 20 gm 23Mfg 2023-03 · Exp 2025-02 Assay of NeomycinAssay CDL KolkataCDSCO lab Jul 2023
Chlorpheniramine Maleate Tablets I.P. 4 mg 745Mfg 2022-07 · Exp 2024-06 Related SubstancesRelated substances CDL KolkataCDSCO lab Nov 2022
Folic Acid & Ferrous Sulphate Tablets I.P. (IFA Large) 84Mfg 2021-02 · Exp 2023-01 DescriptionDescription CDL KolkataCDSCO lab Sep 2021
Folic Acid & Ferrous Sulphate Tablets I.P. (IFA Large) 086Mfg 2021-02 · Exp 2023-01 DescriptionDescription CDL KolkataCDSCO lab Aug 2021
Folic Acid & Ferrous Sulphate Tablets I.P. (IFA Large) 017Mfg 2021-01 · Exp 2022-12 DescriptionDescription CDL KolkataCDSCO lab Aug 2021
Folic Acid & Ferrous Sulphate Tablets I.P. (IFA Large) 085Mfg 2021-02 · Exp 2023-01 DescriptionDescription CDL KolkataCDSCO lab Aug 2021
Folic Acid & Ferrous Sulphate Tablets I.P. (IFA Large) 154Mfg 2021-02 · Exp 2023-01 DescriptionDescription CDL KolkataCDSCO lab Aug 2021
Folic Acid & Ferrous Sulphate Tablets I.P. (IFA Large) 150Mfg 2021-02 · Exp 2023-01 DescriptionDescription CDL KolkataCDSCO lab Aug 2021
Povidone -Iodine Ointment U.S.P. 20 gm 005Mfg 2019-02 · Exp 2021-01 Assay of Available IodineAssay CDL KolkataCDSCO lab Apr 2020

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.